FDA Gives Plavix a 6 Month Extension-Patent Now Expires on May 17 2012–In Europe Patent Expired in 2009
Posted Jan 26 2011 3:51am
Well the patients in the US have to wait a little longer and it is amazing that in Europe as the title suggests has generics available. In May of 2010 Plavix was given a ruling by the FDA to establish a black box warning too.
In addition CVS announced 13 drug therapies that will be included in the initial offering of their integrated Genetic Benefit Management service and Plavix is one of them. The firms said that they are offering the industry's first Best Test Genetics Network, which coordinates pharmacogenomic testing for members of CVS Caremark's network. BD
Sanofi-Aventis SA and Bristol-Myers Squibb Co. Tuesday said the U.S. Food and Drug Administration granted them an extra six months to exclusively market their top-selling blood-thinner Plavix in the U.S.
In a joint statement, the two companies said the FDA gave them a pediatric exclusivity for Plavix, and that their exclusive right to jointly market the world's second-biggest selling drug in the U.S. is now scheduled to expire on May 17, 2012.